S100 calcium-binding protein A8 exacerbates deep vein thrombosis in vascular endothelial cells

Junyu Chi1, Qitao Wang1, Zhen Wang1

  • 1Vascular Gland Surgery, The First Affiliated Hospital of Hebei North University, Zhangjiakou, 075000, Hebei, China.

Scientific Reports
|January 4, 2025
PubMed

Insights

S100A8 protein is linked to deep vein thrombosis (DVT) development. This protein may worsen DVT by increasing inflammation and thrombus formation via the NLRP3/Caspase-1/IL-1β pathway.

Area of Science:

  • Biomedical research
  • Vascular biology
  • Thrombosis research

Background:

  • Inflammation and vascular endothelial damage are key factors in deep vein thrombosis (DVT) development.
  • The S100 calcium-binding protein A8 (S100A8) has been implicated in these processes.

Purpose of the Study:

  • To investigate the association between S100A8 and DVT.
  • To elucidate the role of S100A8 in the pathogenesis of DVT.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to measure S100A8 and interleukin-1 beta (IL-1β) levels in blood samples from DVT patients and controls.
  • Human umbilical vein endothelial cells were activated with recombinant S100A8.
  • A rat model of DVT was established.

Main Results:

  • Elevated S100A8 and IL-1β levels were observed in DVT patients compared to controls.
  • S100A8 activation of endothelial cells promoted inflammatory responses.
  • Infiltration of S100A8 was found to sustain local inflammation and thrombus formation in the DVT model.

Conclusions:

  • S100A8 plays a significant role in DVT development.
  • S100A8 may exacerbate DVT by amplifying the NLRP3/Caspase-1/IL-1β signaling pathway in vascular endothelial cells, contributing to inflammation and thrombosis.